Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

ConclusionsPeficitinib 50, 100, and 150 mg once daily was effective in treating active RA, without causing a significant risk for AEs.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research